Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SCHOTT Increases Sales, Earnings in 2020 - Ink World Magazine

What are you searching for?

Sign in
Flexible Electronics News

SCHOTT Increases Sales, Earnings in 2020

Sales rise by 2.2% to €2.24 billion, EBIT of €288 million.

Author Image

By: DAVID SAVASTANO

Contributing Editor, Coatings World and Ink World, Coatings World and Ink World Magazine

Like many companies, the effects of the COVID-19 pandemic were clearly felt by Schott in parts of the portfolio. However, its pharmaceutical business did very well, driving overall growth in 2020.

“We stayed on course even in these difficult economic times. Therefore, we are quite satisfied with the past fiscal year,” said Dr. Frank Heinricht, chairman of the Board of Management. “This is largely thanks to the groundwork we have done in recent years. We have invested consistently, introduced many innovations to the market and have demonstrated stringent portfolio management.”

Sales rose by 2.2% to €2.24 billion. Operating profit (EBIT) also improved, and now stands at €288 million. The number of employees rose to around 16,500, 5,900 of whom are based in Germany.

Even before COVID-19, SCHOTT invested approximately €320 million or an increase of around 24%, including a new building for pharmaceutical packaging in Müllheim in the German state of Baden, a new plant in China and new melting units in India, both for pharmaceutical tubing production.

The Fight Against COVID-19

SCHOTT currently produces more than 11 billion pharmaceutical packages for vaccines and liquid medications every year. Three out of four projects worldwide that either already manufacture or are still researching a COVID-19 vaccine use glass vials from SCHOTT.

The company will have delivered enough vials for two billion vaccine doses by the end of 2021. SCHOTT has already been investing in its production capacity since the spring of 2019 and was therefore able to ramp up capacities quickly during the pandemic. To achieve a further boost, SCHOTT will once again increase last year’s record investments by spending €350 million. 

Add us as a preferred source on Google

Get the latest Ink World magazine news, insights and analysis in your Google Search and AI experiences.

Add Ink World magazine as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters